RO7227166,Obinutuzumab,Glofitamab,Tocilizumab
Roche,JW Pharma
['dlbcl', 'lymsm', 'glofitamab']
#glofitamab now us fda approved for #dlbcl after 2 prior lines! highly potent (cr43%),fixed course, durable responses. this is great for patients let's hope row follows! proud to have contributed to the data underpinning this . #lymsm #icml17 #icmlugano 
Haem/onc @Haem_pmcc_rmh in Melbourne. #Lymphoma Lead #CART Early phase trials. Lymphoma co-Chair @ALLGtrials Views are my own. #lymsm